3490 J . Org. Chem., Vol. 63, No. 10, 1998
Notes
11a : 1H NMR (DMSO-d6) δ 1.64 (s, 48H, NAc), 1.77 (m, 16H,
H-3ax), 1.89, 1.99, 2.00, 2.01 (4s, 192H, OAc’s), 2.22 (bs, 56H,
b-CH2), 2.45-2.99 (m, 76H, a-CH2, c-CH2, H-3eq), 3.19-3.40
(2m, 56H, d-CH2), 3.52-3.60 (m, 56H, e-CH2), 3.53 (s, 48H,
OCH3), 3.59-3.79 (2m, 32H, H-5, H-6), 4.09 (m, 16H, H-9), 4.28
(m, 16H, H-9′), 4.69 (ddd, 16H, H-4), 5.13 (m, 16H, H-7), 5.19
(m, 16H, H-8), 7.38 (d, 32H, J ortho,meta 8.2 Hz, H-ortho), 7.54 (d,
32H, H-meta), 7.62 (d, 16H, J 5,NHAc 9.5 Hz, NHAc), 7.80-8.15
(3bs, 44H, NHC(S)NHPh, amide NH’s), 9.90 (bs, 16H, NHC(S)-
NHPh); 13C NMR (DMSO-d6) δ 20.6, 20.8 (OAc’s), 22.6 (NAc),
37.7 (C-3), 37.8 (C-d), 40.5 (C-a), 43.4 (C-e), 47.7 (C-5), 52.8
(OCH3), 61.7 (C-9), 67.4 (C-7), 68.9 (C-8), 69.5 (C-4), 74.1 (C-6),
87.3 (C-2), 122.0 (C-meta), 122.2 (C-para), 1366.4 (C-ortho), 141.3
(C-ipso), 167.8-170.1 (CdO’s), 180.4 (CdS).
Ta ble 1. In h ibition of Bin d in g of Hu m a n r1-Acid
Glycop r otein to Lim a x fla vu s by Sia lod en d r im er s
relative
compound
IC50 (nM)a
242
potencya
phenyl 2-thio-R-sialoside 6a
PAMAM-based 4mer 9b
PAMAM-based 8mer 10b
PAMAM-based 16mer 11b
PAMAM-based 32mer 12b
3,3′-iminobis(propylamine)-
based 4mer4,5
1
69.2 (277)
21.5 (172)
2.89 (46.2)
1.13 (36.2)
37.2 (149)
3.5 (0.87)
11 (1.4)
84 (5.2)
210 (6.7)
6.5 (1.6)
a
Values in parentheses are based on a per sialoside residue.
12a : 1H NMR (DMSO-d6) δ 1.65 (s, 96H, NAc), 1.78 (m, 32H,
H-3ax), 1.90, 2.00, 2.01, 2.02 (4s, 384H, OAc’s), 2.25 (bs, 120H,
b-CH2), 2.52-2.85 (m, 156H, a-CH2, c-CH2, H-3eq), 3.00-3.60
(m, 240H, d-CH2, e-CH2), 3.56 (s, 96H, OCH3), 3.59-3.79 (2m,
64H, H-5, H-6), 4.09 (m, 32H, H-9), 4.28 (m, 32H, H-9′), 4.69
(ddd, 32H, H-4), 5.13 (m, 32H, H-7), 5.19 (m, 32H, H-8), 7.38 (d,
64H, J ortho,meta 8.2 Hz, H-ortho), 7.54 (d, 64H, H-meta), 7.62 (d,
32H, J 5,NHAc 9.5 Hz, NHAc), 7.75-8.15 (m, 92H, NHC(S)NHPh,
amide NH’s), 9.90 (bs, 32H, NHC(S)NHPh); 13C NMR (DMSO-
d6) δ 20.6, 20.7 (OAc’s), 22.5 (NAc), 32.4 (C-b), 37.8 (C-3), 43.4
(C-e), 47.6 (C-5), 49.4 (C-c), 52.8 (OCH3), 61.7 (C-9), 67.3 (C-7),
68.9 (C-8), 69.5 (C-4), 74.1 (C-6), 87.3 (C-2), 122.0 (C-meta), 122.2
(C-para), 136.4 (C-ortho), 141.3 (C-ipso), 167.7-170.1 (CdO’s),
180.4 (CdS).
P r ep a r a tion of F u lly Dep r otected P AMAM-Ba sed r-Th i-
osia lod en d r im er s 9b, 10b, 11b, a n d 12b. Typ ica l P r oce-
d u r e. To peracetylated glycodendrimer 9b (47.2 mg, 0.015
mmol) dissolved in DMSO (0.5 mL) was added 1 M NaOMe in
MeOH (5 mL), and the solution was stirred at 25 °C. After 1 h,
MeOH was evaporated under reduced pressure and 0.05 M
NaOH (5 mL) added. After 1.5 h, the solution was neutralized
with 1 M HCl and the solvent removed by lyophilization. The
resulting residue was purified by dialysis against 1:1 DMSO/
H2O (MW cutoff 2 kDa) and then freeze-dried. Compound 9b
was isolated as a white, spongy solid in 80% yield (28.9 mg, 0.012
mmol).
Fully deprotected R-thiosialodendrimers 10b, 11b, and 12b
were obtained in the same manner from glycodendrimers 10a ,
11a , and 12a in 79, 100, and 100% yields, respectively.
9b: 1H NMR (DMSO-d6) δ 1.66 (dd, 4H, J 11.9 Hz, H-3ax),
1.84 (s, 12H, NAc), 2.25-2.59 (m, 12H, b-CH2, H-3eq), 2.63-
3.00 (m, 12H, a-CH2, c-CH2), 3.05-3.60 (m, 44H, d-CH2, e-CH2,
and NeuAc residues excluding above), 4.27, 4.59, 4.72, 5.18 (4bs,
16H, OH’s), 7.22-8.15 (4m, 28H, amide NH’s, NHC(S)NHPh,
H-ortho, H-meta, NHAc), 9.88-10.20 (4bs, 4H, NHC(S)NHPh);
13C NMR (DMSO-d6) δ 22.6 (NAc), 37.8 (C-d), 40.4 (C-3), 40.7
(C-a), 42.1 (C-c), 43.2 (C-e), 51.8 (C-5), 63.2 (C-9), 66.8 (C-7), 68.7
(C-8), 71.3 (C-4), 76.1 (C-6), 86.5 (C-2), 121.5, 122.2 (C-meta,
C-para), 136.2 (C-ortho), 141.5 (C-ipso), 169.2-172.1 (CdO’s),
180.4 (CdS).
4.11 (m, 1H, H-9), 4.31 (m, 1H, H-9′), 4.83 (ddd, 1H, J 3ax,4 11.7
Hz, J 4,5 10.3 Hz, H-4), 5.10 (d, 1H, J NH,5 9.9 Hz, NH), 5.23-5.27
(m, 2H, H-7, H-8), 7.16 (d, 2H, J ortho,meta 8.6 Hz, H-ortho), 7.45
(d, 1H, H-meta); 13C NMR (CDCl3) δ 20.7, 20.9 (OAc’s), 23.1
(NAc), 38.1 (C-3), 49.3 (C-5), 52.8 (OCH3), 60.3 (C-9), 62.0 (C-7),
67.5 (C-7), 69.2 (C-4), 69.4 (C-8), 74.5 (C-6), 126.0 (C-ortho), 127.9
(NdCdS), 132.9 (C-para), 137.1 (C-ipso), 137.2 (C-meta), 167.5-
170.8 (CdO’s); FAB-MS (pos.) calcd for C27H32N2O12S 640.14;
found 641.2 (M+ + 1, 18.0). Anal. Calcd for C27H32N2O12S: C,
50.62; H, 5.03; N, 4.37. Found: C, 50.23; H, 5.10; N, 4.52.
P r ep a r a tion of P er a cetyla ted P AMAM-Ba sed r-Th io-
sia lod en d r im er s 9a , 10a , 11a , a n d 12a . Typ ica l P r oced u r e.
A methanolic solution of amine-terminated tetravalent Starburst
PAMAM dendritic core 1 (23.0 mg of a 36.02% (w/w) solution in
MeOH, 0.016 mmol, Dendritech (Midland, MI)) was evaporated
under reduced pressure. The resulting residue was redissolved
in CH2Cl2 (5 mL) and the solution re-evaporated. This was
repeated three times. Compound 1 was then dissolved in CH2-
Cl2 (5 mL), to this was added diisopropylethylamine (DIPEA,
8.3 mg, 0.064 mmol), and the solution was stirred at room
temperature. Sialic acid isothiocyanato derivative 8 (50.0 mg,
0.078 mmol) dissolved in CH2Cl2 (5 mL) was added dropwise to
the stirred solution and the reaction left at 25 °C. After 20 h,
the reaction mixture was concentrated in vacuo and then
dialyzed against 1:1 DMSO/H2O (MW cutoff 2 kDa). The
resulting solution was lyophilized to give tetravalent PAMAM-
based R-thiosialodendrimer 9a as an off-white solid in 94% yield
(47.2 mg, 0.015 mmol).
Fully protected R-thiosialodendrimers 10a , 11a , and 12a were
obtained in the same manner from Starburst PAMAM dendritic
cores 2, 3, and 4 using DMF as the reaction solvent, in 71, 100,
and 100% yields, respectively.
9a : 1H NMR (DMSO-d6) δ 1.65 (s, 12H, NAc), 1.77 (dd, 4H, J
12.1 Hz, H-3ax), 1.90, 1.99, 2.00, 2.02 (4s, 48H, OAc’s), 2.28 (bs,
8H, b-CH2), 2.52-2.99 (3m, 16H, a-CH2, c-CH2, H-3eq), 3.25 (m,
8H, d-CH2), 3.52-3.60 (m, 8H, e-CH2), 3.54 (s, 12H, OCH3),
3.59-3.79 (2m, 8H, H-5, H-6), 4.09 (dd, 4H, J 8,9 6.0 Hz, J 9,9′ 12.2
Hz, H-9), 4.28 (dd, 4H, J 8,9′ 2.5 Hz, H-9′), 4.69 (ddd, 4H, H-4),
5.13 (m, 4H, H-7), 5.19 (m, 4H, H-8), 7.38 (d, 8H, J ortho,meta 8.2
Hz, H-ortho), 7.54 (d, 8H, H-meta), 7.62 (d, 4H, J 5,NHAc 9.5 Hz,
NHAc), 8.00 (bs, 4H, NHC(S)NHPh), 8.05 (bs, 4H, amide NH’s),
9.86 (bs, 4H, NHC(S)NHPh); 13C NMR (DMSO-d6) δ 20.6, 20.8
(OAc’s), 22.6 (NAc), 32.4 (C-b), 37.7 (C-3), 37.8 (C-d), 40.5 (C-a),
43.4 (C-e), 47.7 (C-5), 48.8 (C-c), 52.8 (OCH3), 61.7 (C-9), 67.4
(C-7), 68.9 (C-8), 69.5 (C-4), 74.1 (C-6), 87.3 (C-2), 122.0 (C-meta),
122.2 (C-para), 136.4 (C-ortho), 141.3 (C-ipso), 167.8-170.1
(CdO’s), 180.4 (CdS).
10b: 1H NMR (DMSO-d6) δ 1.66 (m, 8H, H-3ax), 1.83 (s, 24H,
NAc), 2.25-2.61 (m, 32H, b-CH2, H-3eq), 2.63-3.00 (m, 28H,
a-CH2, c-CH2), 3.05-3.68 (m, 104H, d-CH2, e-CH2, and NeuAc
residues excluding above), 4.27, 4.59, 4.98, 5.20 (4bs, 32H, OH’s),
7.22-8.15 (4m, 60H, amide NH’s, NHC(S)NHPh, H-ortho,
H-meta, NHAc), 9.88 (bs, 8H, NHC(S)NHPh); 13C NMR (DMSO-
d6) δ 22.7 (NAc), 37.8 (C-d), 40.5 (C-3), 40.7 (C-a), 43.4 (C-e),
51.9 (C-5), 63.2 (C-9), 66.8 (C-7), 68.8 (C-8), 71.3 (C-4), 76.1 (C-
6), 86.5 (C-2), 121.8 (C-meta), 136.4 (C-ortho), 169.3-171.6
(CdO’s), 180.4 (CdS).
1
10a : H NMR (DMSO-d6) δ 1.64 (s, 24H, NAc), 1.77 (dd, 8H,
J 12.1 Hz, H-3ax), 1.90, 1.99, 2.00, 2.02 (4s, 96H, OAc’s), 2.25
(bs, 12H, b-CH2), 2.55-2.95 (2m, 24H, a-CH2, b-CH2, H-3eq),
3.25-3.49 (2m, 48H, c-CH2, d-CH2), 3.52-3.60 (m, 24H, e-CH2),
3.54 (s, 24H, OCH3), 3.59-3.79 (2m, 16H, H-5, H-6), 4.09 (m,
8H, H-9), 4.28 (dd, 8H, J 8,9′ 2.5 Hz, J 9,9′ 12.2 Hz, H-9′), 4.69 (ddd,
8H, H-4), 5.13 (m, 8H, H-7), 5.19 (m, 8H, H-8), 7.38 (d, 16H,
J ortho,meta 8.2 Hz, H-ortho), 7.54 (d, 16H, H-meta), 7.62 (d, 8H,
J 5,NHAc 9.5 Hz, NHAc), 8.00-8.20 (2m, 20H, NHC(S)NHPh,
amide NH’s), 9.90 (bs, 8H, NHC(S)NHPh); 13C NMR (DMSO-
d6) δ 20.5, 20.7 (OAc’s), 22.5 (NAc), 37.6 (C-3), 37.7 (C-d), 40.4
(C-a), 43.3 (C-e), 47.6 (C-5), 49.4 (C-c), 52.7 (OCH3), 61.6 (C-9),
67.3 (C-7), 68.9 (C-8), 69.4 (C-4), 74.0 (C-6), 87.2 (C-2), 121.9
(C-meta), 122.7 (C-para), 136.3 (C-ortho), 141.2 (C-ipso), 167.7-
170.0 (CdO’s), 180.4 (CdS).
11b: 1H NMR (DMSO-d6) δ 1.66 (dd, 16H, J 12.0 Hz, H-3ax),
1.83 (s, 48H, NAc), 2.25-2.62 (m, 72H, b-CH2, H-3eq), 2.63-
3.00 (m, 60H, a-CH2, c-CH2), 3.05-3.70 (m, 224H, d-CH2, e-CH2,
and NeuAc residues excluding above), 4.27, 4.59, 4.72, 5.18 (4bs,
64H, OH’s), 7.22-8.15 (4m, 124H, amide NH’s, NHC(S)NHPh,
H-ortho, H-meta, NHAc), 9.90 (bs, 16H, NHC(S)NHPh); 13C
NMR (DMSO-d6) δ 22.7 (NAc), 37.9 (C-d), 40.5 (C-3), 40.7 (C-a),
43.3 (C-e), 51.9 (C-5), 63.2 (C-9), 66.8 (C-7), 68.7 (C-8), 71.3 (C-
4), 76.1 (C-6), 86.5 (C-2), 121.8, (C-meta), 136.4 (C-ortho), 141.2
(C-ipso), 169.3-171.6 (CdO’s), 180.4 (CdS).
12b: 1H NMR (DMSO-d6) δ 1.66 (dd, 32H, J 11.9 Hz, H-3ax),
1.84 (s, 96H, NAc), 2.25 (bs, 120H, b-CH2), 2.50-2.80 (m, 154H,
a-CH2, c-CH2, H-3eq), 3.05-3.70 (m, 464H, d-CH2, e-CH2, and